You are here

  • Home
  • Archive
  • Volume 63, Issue 4
  • 5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer?

Article info

Article menu
Download PDFPDF
Commentary
5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer?

Authors

  • Abbes Belkhiri Department of Surgery and Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles
  • Wael El-Rifai Department of Surgery and Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Wael El-Rifai and Dr Abbes Belkhiri, Department of Surgery and Department of Cancer Biology, Vanderbilt University Medical Center, 760 Preston Research Building, 2220 Pierce Ave, Nashville, TN 37232-6308, USA; wael.el-rifai{at}vanderbilt.edu or abbes.belkhiri{at}vanderbilt.edu
View Full Text

Citation

Belkhiri A, El-Rifai W
5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer?
Gut 2014;63:538-539.

Publication history

  • Received May 29, 2013
  • Revised June 3, 2013
  • Accepted June 5, 2013
  • First published June 27, 2013.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions